NCEL
$2.37-0.08 (-3.27%)
Market ClosedAs of Mar 20, 8:00 PM UTC
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.37
Potential Upside
5%
Whystock Fair Value$2.49
Price
UndervaluedFair ValueOvervalued
Fundamentals
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.80M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.57
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
122.51%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.02
